Elvis Patel
FDA investigator
Appears on 3 documents from 2025, mostly at sites in California. Most often cites control of microbiological contamination (21 CFR 211.113).
- 3
- Documents on file
- 6.0
- Observations per 483
- 2025
- First seen
- 2025
- Most recent
What they cite most
From 18 observations- 21 CFR 211.113Control of microbiological contamination6
- 21 CFR 211.160General requirements3
- 21 CFR 211.192Production record review3
- 21 CFR 211.22Responsibilities of quality control unit3
- 21 CFR 211.42Design and construction features3
Activity by year
2025: 3
Where
California 2 · Indiana 1
Often inspects with
Is Elvis Patel coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
3 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2025-05-20 | 483 Eli Lilly and CompanyMay 20, 2025 · Indianapolis, Indiana | Indianapolis, Indiana | 6 | |
| 2025-05-09 | 483 Ajinomoto Althea, IncMay 9, 2025 · San Diego, California | San Diego, California | 6 | |
| 2025-05-09 | 483 PCI San Diego, Inc.May 9, 2025 · San Diego, California | San Diego, California | 6 |
About this profile
What does Elvis Patel inspect?
Elvis Patel appears on 3 documents on file covering 2 sites, mostly in California.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.160 and 21 CFR 211.192.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Elvis Patel is dated May 20, 2025.